China Pharma Inc. (CPHI)

AMEX: CPHI · Real-Time Price · USD

1.99

-0.16 (-7.44%)

At close: May 01, 2025, 3:58 PM

1.99

0.06%

Pre-market: May 02, 2025, 07:12 AM EDT

China Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	626.88K	1.42M	2.03M	4.86M	957.65K	1.07M	1.19M	2.03M	2.67M
Short-Term Investments	626.88B	65.92K	13.78K	91.36K	53.74K	45.76K	20.58K	39.87K	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	-11.82M	-13.56M	-15.8M	-16.66M	17.07M	23.72M	35.5M
Receivables	232.14B	662.39K	464.45K	835.4K	583.28K	682.01K	1.09M	2.46M	4.22M
Inventory	2,266.2B	3.73M	2.95M	3.34M	3.71M	3.59M	5.05M	6.41M	7.31M
Other Current Assets	145.22B	67.93K	444.64K	471.00	2.24K	109.91K	1.27M	709.8K	1.09M
Total Current Assets	3,270.4B	6M	5.96M	9.09M	5.32M	5.58M	8.75M	12.29M	17.52M
Property-Plant & Equipment	4.53M	6.82M	9.61M	12.97M	15.18M	16.05M	18.88M	23.11M	24.56M
Goodwill & Intangibles	7.09M	3.65M	2.21M	589.62K	613.83K	609.37K	676.05K	831.77K	940.33K
Total Long-Term Assets	11.62M	10.47M	11.82M	13.56M	15.8M	16.66M	36.63M	47.66M	61M
Total Assets	15.07M	16.47M	17.78M	22.65M	21.12M	22.24M	45.38M	59.95M	78.52M
Account Payables	225.11K	966.42K	667.08K	926.75K	1.23M	1.37M	1.06M	1.14M	3.06M
Deferred Revenue	n/a	90.51K	520.29K	210.03K	719.79K	505.4K	525.65K	581.13K	811.23K
Short-Term Debt	2.16M	3.1M	8.72M	7.11M	6.47M	4.33M	3.46M	3.02M	2.53M
Other Current Liabilities	5,017.3B	12K	372.58K	327.03K	297.49K	n/a	n/a	n/a	n/a
Total Current Liabilities	5,017.3B	6.82M	12.74M	10.51M	11.4M	10.05M	10.05M	9.23M	10.4M
Long-Term Debt	1.39M	1.41M	n/a	5.25M	904.23K	2.15M	4.36M	6.92M	8.64M
Other Long-Term Liabilities	-731.2B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	2.12M	2.19M	754.7K	6.12M	1.71M	2.95M	5.13M	7.65M	9.21M
Total Liabilities	7,139.6B	9.01M	13.49M	16.63M	13.11M	13M	15.18M	16.88M	19.61M
Total Debt	3.59M	4.63M	8.76M	12.49M	7.43M	4.55M	7.82M	9.93M	11.17M
Common Stock	32.62B	10.63K	74.91K	47.34K	45.58K	43.58K	43.58K	43.58K	43.58K
Retained Earnings	-44.03M	-39.29M	-36.21M	-32.24M	-28.84M	-25.97M	-5.27M	5.48M	24.76M
Comprehensive Income	11,319.6B	11.45M	11.57M	12.56M	12.35M	11.58M	11.84M	13.96M	10.52M
Shareholders Equity	7,747.9B	7.45M	4.29M	6.02M	8M	9.24M	30.2M	43.07M	58.91M
Total Investments	626.88B	65.92K	13.78K	91.36K	53.74K	45.76K	20.58K	39.87K	n/a